Patents by Inventor Krishna K. Niyogi

Krishna K. Niyogi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230323480
    Abstract: The present disclosure relates to methods of screening for gain of function mutations in non-coding regions of target genes. The target genes may be NPQ genes, including photosystem II subunit S (PsbS), zeaxanthin epoxidase (ZEP), and violaxanthin de-epoxidase (VDE). The present disclosure further relates to methods of improving commercial crop plants or crop seeds by introducing gain of function mutations in non-coding regions of target genes, and to improved commercial crop plants or crop seeds produced by the methods.
    Type: Application
    Filed: April 11, 2023
    Publication date: October 12, 2023
    Applicant: The Regents of the University of California
    Inventors: Dhruv Patel, Krishna K. Niyogi
  • Publication number: 20230183731
    Abstract: The present disclosure provides a transgenic plant comprising one or more nucleotide sequences encoding polypeptides selected from photosystem II subunit S (PsbS), zeaxanthin epoxidase (ZEP), and violaxanthin de-epoxidase (VDE), operably linked to at least one expression control sequence. Expression vectors for making transgenic plants, and methods for increasing biomass production and/or carbon fixation and/or growth in a plant comprising increasing expression of at least one of PsbS, ZEP and VDE polypeptides are also provided.
    Type: Application
    Filed: November 18, 2022
    Publication date: June 15, 2023
    Inventors: Stephen P. Long, Johannes Kromdijk, Katarzyna Glowacka, Krishna K. Niyogi, Laurie Beth Leonelli, Stephane T. Gabilly
  • Patent number: 11572569
    Abstract: The present disclosure provides a transgenic plant comprising one or more nucleotide sequences encoding polypeptides selected from photosystem II subunit S (PsbS), zeaxanthin epoxidase (ZEP), and violaxanthin de-epoxidase (VDE), operably linked to at least one expression control sequence. Expression vectors for making transgenic plants, and methods for increasing biomass production and/or carbon fixation and/or growth in a plant comprising increasing expression of at least one of PsbS, ZEP and VDE polypeptides are also provided.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: February 7, 2023
    Assignees: The Board of Trustees of The University Of Illinois, The Regents of the University of California
    Inventors: Stephen P. Long, Johannes Kromdijk, Katarzyna Glowacka, Krishna K. Niyogi, Laurie Leonelli, Stephane T. Gabilly
  • Patent number: 11124819
    Abstract: The disclosure is directed to nucleic acid, host cell, and polypeptide compositions encoded by the unicellular green alga Chromochloris zofingiensis, methods of making such compositions, and method of using the compositions to produce astaxanthin.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: September 21, 2021
    Assignee: The Regents of the University of California
    Inventors: Melissa S. Roth, Krishna K. Niyogi, Sean D. Gallaher, Sabeeha Merchant
  • Publication number: 20200283788
    Abstract: Aspects of the present disclosure relate to methods of cultivating genetically altered plants with increased activity of the PsbS protein. These genetically altered plants have increased water use efficiency and substantially similar photosynthetic efficiency as compared to WT plants grown under the same conditions.
    Type: Application
    Filed: March 4, 2020
    Publication date: September 10, 2020
    Inventors: Stephen P. Long, Katarzyna Glowacka, Johannes Kromdijk, Krishna K. Niyogi, Lauriebeth Leonelli
  • Patent number: 10480003
    Abstract: Methods and compositions to introduce a synthetic pathway based on the 3-hydroxypropionate bicycle into an organism such as the model cyanobacterium, Synechococcus elongatus sp. PCC 7942. The heterologously expressed pathway acts as a photorespiratory bypass as well as an additional carbon fixation cycle orthogonal to the endogenous Calvin-Benson cycle. We demonstrate the function of all six introduced enzymes, which not only has implications on increasing net-photosynthetic productivity, but also key enzymes in the pathway are involved in high-value products that are of biotechnological interest, such as 3-hydroxypropionate.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: November 19, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Cheryl A. Kerfeld, Patrick Shih, Jan Zarzycki, Krishna K. Niyogi
  • Publication number: 20190292556
    Abstract: Methods and compositions for improving photosynthesis by eliminating a sustained photoprotective mechanism by mutating or silencing the Chloroplastic Lipocalin (CHL) gene whereby photosynthesis of the plants increases. The sustained photoprotective mechanism negatively regulated by the Suppressor of Quenching 1 protein involves the chloroplastic lipocalin and occurs in the peripheral antenna of photosystem II.
    Type: Application
    Filed: February 6, 2019
    Publication date: September 26, 2019
    Applicant: The Regents of the University of California
    Inventors: Alizee Malnoe, Krishna K. Niyogi
  • Publication number: 20190233867
    Abstract: Provided herein are nucleic acid, host cell, and polypeptide compositions encoded by the unicellular green alga Chromochloris zofingiensis, methods of making such compositions, and method of using the compositions to produce astaxanthin.
    Type: Application
    Filed: March 15, 2018
    Publication date: August 1, 2019
    Inventors: Melissa S. Roth, Krishna K. Niyogi, Sean D. Gallaher, Sabeeha Merchant
  • Patent number: 10336989
    Abstract: This disclosure provides Chlamydomonas violaxanthin de-epoxidase (CVDE) gene, polypeptides, and variants thereof as well as host cells that are genetically modified to express a CVDE polypeptide or variant. The disclosure additionally provides methods of producing such a genetically modified host cell and methods of using the cells , e.g., to increase zeaxanthin production.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: July 2, 2019
    Assignee: The Regents of the University of California
    Inventors: Krishna K. Niyogi, Zhirong Li, Rachel Dent, Graham Peers
  • Publication number: 20190161765
    Abstract: The present disclosure provides a transgenic plant comprising one or more nucleotide sequences encoding polypeptides selected from photosystem II subunit S (PsbS), zeaxanthin epoxidase (ZEP), and violaxanthin de-epoxidase (VDE), operably linked to at least one expression control sequence. Expression vectors for making transgenic plants, and methods for increasing biomass production and/or carbon fixation and/or growth in a plant comprising increasing expression of at least one of PsbS, ZEP and VDE polypeptides are also provided.
    Type: Application
    Filed: May 26, 2017
    Publication date: May 30, 2019
    Applicants: The Board of Trustees of the University of Illinois, The Regents of the University of California
    Inventors: Stephen P. Long, Johannes Kromdijk, Katarzyna Glowacka, Krishna K. Niyogi, Laurie Leonelli, Stephane T. Gabilly
  • Publication number: 20180057800
    Abstract: This disclosure provides Chlamydomonas violaxanthin de-epoxidase (CVDE) gene, polypeptides, and variants thereof as well as host cells that are genetically modified to express a CVDE polypeptide or variant. The disclosure additionally provides methods of producing such a genetically modified host cell and methods of using the cells , e.g., to increase zeaxanthin production.
    Type: Application
    Filed: June 16, 2017
    Publication date: March 1, 2018
    Inventors: Krishna K. Niyogi, Zhirong Li, Rachel Dent, Graham Peers
  • Publication number: 20170088850
    Abstract: Methods and compositions to introduce a synthetic pathway based on the 3-hydroxypropionate bicycle into an organism such as the model cyanobacterium, Synechococcus elongatus sp. PCC 7942. The heterologously expressed pathway acts as a photorespiratory bypass as well as an additional carbon fixation cycle orthogonal to the endogenous Calvin-Benson cycle. We demonstrate the function of all six introduced enzymes, which not only has implications on increasing net-photosynthetic productivity, but also key enzymes in the pathway are involved in high-value products that are of biotechnological interest, such as 3-hydroxypropionate.
    Type: Application
    Filed: August 5, 2016
    Publication date: March 30, 2017
    Applicant: The Regents of the University of California
    Inventors: Cheryl A. Kerfeld, Patrick Shih, Jan Zarzycki, Krishna K. Niyogi